Bristol-Myers Squibb
BMY
BMY
2,365 hedge funds and large institutions have $102B invested in Bristol-Myers Squibb in 2021 Q1 according to their latest regulatory filings, with 158 funds opening new positions, 993 increasing their positions, 938 reducing their positions, and 119 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.69% less ownership
Funds ownership: 73.64% → 72.94% (-0.69%)
1% less capital invested
Capital invested by funds: $104B → $102B (-$1.55B)
10% less funds holding in top 10
Funds holding in top 10: 78 → 70 (-8)
Holders
2,365
Holding in Top 10
70
Calls
$1.15B
Puts
$1.04B
Top Buyers
| 1 | +$322M | |
| 2 | +$254M | |
| 3 | +$245M | |
| 4 |
JP Morgan Chase
New York
|
+$230M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$167M |
Top Sellers
| 1 | -$716M | |
| 2 | -$470M | |
| 3 | -$384M | |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$279M |
| 5 |
Bank of New York Mellon
New York
|
-$259M |